Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients

J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.06.006. Epub 2020 Jun 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Critical Illness
  • Etoposide / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Topoisomerase II Inhibitors / therapeutic use*

Substances

  • Topoisomerase II Inhibitors
  • Etoposide